Recently, the presence of small, dense low-density lipoprotein (LDL) has been recognized as a risk factor for coronary heart disease. There has been little work on correlates of LDL size in population-based studies and none in Mexican Americans. We examined the relationship of LDL size and pattern to 
I
ncreased concentrations of low-density lipoprotein cholesterol (LDL-C) are widely recognized as a risk factor for coronary heart disease (CHD). 1 -2 There is considerable heterogeneity in the size and density of LDL particles. 34 Small, dense LDL particles have been recognized as a risk factor for CHD in several studies, although this association may not be statistically independent of triglyceride concentrations. 57 Austin et al 6 reports that most individuals can be assigned to one of two LDL subclass patterns (B or A). Relatively few subjects have an intermediate (I) pattern. Small, dense LDL (pattern B) is associated with diabetes, hyperinsulinemia, increased triglyceride levels, decreased highdensity lipoprotein cholesterol (HDL-C) concentrations, male gender, and a high-carbohydrate diet. 712 In two family studies, LDL subclass pattern was found to have strong genetic determinants. 13 - 14 Nishina et al 15 have recently described a gene for LDL subclass pattern that is linked to the LDL receptor locus on the short arm of chromosome 19. Relatively little information is available on possible ethnic differences in LDL heterogeneity, although related factors are known to exist. Mexican Americans are more obese 15 ' 17 and have increased triglyceride concentrations 16 as well as an increased prevalence 16 - 18 and incidence 19 of diabetes, hyperinsulinemia, 20 and insulin resistance 21 relative to non-Hispanic whites. Recently, we 22 have shown that the predicted risk of cardiovascular mortality estimated by using logistic regression coefficients from the Framingham Study is increased in Mexican Americans. Thus, it is surprising that the prevalence of myocardial infarction is lower in Mexican American men than in non-Hispanic white men and similar in Mexican American women and non-Hispanic white women. 23 Furthermore, lower cardiovascular disease mortality has been reported in Mexican American men than in non-Hispanic men in many areas of the Southwest, including the states of Texas, 24 California, and New Mexico (for summary of references see Reference 23) . Since this protection cannot be accounted for by conventional risk factors, we hypothesized that Mexican Americans might be protected by other, possibly genetic, factors. We 25 have recently shown that lipoprotein(a) concentrations are lower in Mexican Americans than in non-Hispanic whites, a factor that could contribute some protection. Lipoprotein(a) has been shown to have a strong genetic component 26 and to differ widely across ethnic groups.
Although one might expect Mexican Americans to exhibit a type B pattern more commonly than nonHispanic whites because of their increased obesity, hypertriglyceridemia, hyperinsulinemia, and diabetes, all of which are associated with the type B pattern, 8 -12 they might nevertheless lack this pattern on a genetic basis. In this report we describe LDL subclass pattern and LDL size in Mexican Americans and non-Hispanic whites who are participants in the San Antonio Heart Study, a population-based study of diabetes and cardiovascular risk factors. We also examine the relation of LDL size and pattern to obesity, body fat distribution, smoking, alcohol intake, glucose intolerance, hyperinsulinemia, lipids, and lipoproteins.
Methods
The San Antonio Heart Study is a population-based study of diabetes and cardiovascular disease in Mexican Americans and non-Hispanic whites that was designed to separate the effects of ethnicity and socioeconomic status. From 1979 through 1982 (phase I) and from 1984 through 1988 (phase II), we randomly selected households from several San Antonio, Tex, census tracts including low-income (barrio), middle-income (transitional), and high-income (suburban) census tracts.
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The low-income neighborhoods were exclusively Mexican American; the middle-income neighborhoods were approximately 50% Mexican American and 50% nonHispanic white; and the upper-income neighborhoods were composed of 10% Mexican Americans and 90% non-Hispanic whites. To assure adequate numbers of upper-income Mexican Americans for analyses, we sampled all Mexican Americans living in the upper-income census tracts but only a 10% random sample of nonHispanic whites. All men and nonpregnant women 25 through 64 years of age who resided in the randomly selected households were eligible to participate. Mexican Americans were defined as individuals whose ancestry and cultural traditions derived from a Mexican national origin. 28 Detailed descriptions of the 1979 through 1982 survey (phase I) 16 and the 1984 through 1988 survey (phase II) 20 have been previously published. This study was approved by the Institutional Review Board of the University of Texas Health Science Center at San Antonio. All subjects gave informed consent.
In October 1987, we began an 8-year follow-up of the phase I cohort to determine the incidence of noninsulin-dependent diabetes mellitus and cardiovascular disease. 19 This survey was completed in November 1990. Beginning in October 1991, we began a similar 7-year follow-up study of participants in phase II. The present report is based on subjects from the first census tract of the phase II follow-up (a middle-income, transitional neighborhood composed of approximately 50% Mexican Americans and 50% non-Hispanic whites, n=366) and the second census tract (a lower-income, barrio neighborhood composed exclusively of Mexican Americans, n = 100).
At the follow-up examination, blood specimens were obtained after a 12-to 14-hour fast, and a second specimen was obtained 2 hours after administration of a 75-g glucose equivalent load (Orangedex, Custom Laboratories, Baltimore, Md). Plasma glucose concentrations were measured with an Abbott V/P Analyzer (Abbott Laboratories, North Chicago, 111). Insulin was measured with a commercial radioimmunoassay (Diagnostic Products Corp, Los Angeles, Calif). 20 Fasting lipids and lipoproteins were measured by using methods described previously. 16 Anthropometric measurements (height, weight, and waist and hip circumferences) were obtained after participants had removed their shoes and outer garments and donned an examining gown. 17 Waist circumference was measured at the level of the umbilicus, and hip circumference was measured at the level of the greater trochanter. Body mass index (BMI) was calculated as weight (in kilograms) divided by height (in meters) squared. The ratio of waist-to-hip circumferences (WHR) was used as a measure of body fat distribution. Systolic blood pressure (first phase) and diastolic blood pressure (fifth phase) were measured to the nearest digit using a random-zero sphygmomanometer (Hawksley Gelman, Sussex, UK). Three readings were recorded for each individual, and the average of the second and third readings was defined as the subject's blood pressure. Alcohol intake and smoking use were assessed by previously described questionnaires. 29 Estrogen and oral contraceptive use was assessed by self-report. "Premenopausal" was denned as having 10 or more menstrual cycles in the preceding year. "Postmenopausal" was denned as having the last menstrual cycle >1 year before the examination date and/or surgical removal of the uterus and ovaries. Women who were considered to have uncertain menopausal status were excluded from the analyses involving menopausal status.
LDL size and subclass assessment were determined on plasma samples by the method of Krauss and Burke 4 in the laboratory of the Medlantic Research Institute. Gradient gels were obtained from Isolab, Inc, Akron, Ohio, and were standardized using LDL subtractions whose molecular diameter was confirmed by analytical ultracentrifugation (courtesy of Dr R. Krauss, Donner Laboratories, Berkeley, Calif). An LDL size of >257 A was classified as pattern A; LDL size of <253.5 A was classified as pattern B; and LDL size between 253.5 A and 257 A was classified as intermediate (I) unless the size was very close to and the peak had the shape of the A or B pattern. 4 The interassay coefficient of variation for eight control pools (247 through 263 A) ranged from 1.8% to 3.6%.
Statistical techniques included parametric analyses of variance, multiple linear regression, and Spearman correlation coefficients. 30 We confirmed that LDL size was normally distributed by using normal probability plots. The skewness of the LDL size distribution was -0.16 and the kurtosis was -0.71, which also suggested an approximately normal distribution. Triglyceride concentrations were logarithmically transformed to reduce skewness and kurtosis. Statistical analyses were performed on the natural logarithms, and the results were back-transformed into their natural units for presentation in the tables. Adjusted prevalences of LDL subclass patterns B and A were calculated by multiple logistic regression analyses 31 and were evaluated by the x 2 test. 30 Interactions between ethnicity (or sex) and other variables such as obesity and body fat distribution were examined by using both logistic regression and analysis of variance. There were no statistically significant interactions (P>.10). Since we studied Mexican Americans and non-Hispanic whites in both middle-and lowerincome neighborhoods, we considered whether socioeconomic status as assessed by educational attainment might be related to small, dense LDL. However, educational status was not significantly related to LDL size (P>.50) independent of metabolic variables (such as triglyceride, glucose, and insulin concentrations) and is hence excluded from presentation in this report. Table 1 shows anthropometric and metabolic characteristics of subjects according to ethnic group. Fiftyseven percent of the population was female and 67% was Mexican American. Mexican Americans had significantly higher fasting and 2-hour glucose and insulin and fasting triglyceride concentrations than did nonHispanic whites. The percent of pattern B was higher, although not significantly so, in Mexican Americans than in non-Hispanic whites (40.0% and 34.4%, respectively; P=.319). The average size of LDL was significantly lower in Mexican Americans than in non-Hispanic whites (255.8±0.6 and 257.9±0.7 A, respectively; P=.O41).
Results
We initially examined correlates of LDL sizes separately in the two ethnic groups to determine whether they were different in each ethnic group. Correlation coefficients between selected variables and LDL size were very similar in each ethnic group (Table 2) . Therefore, in subsequent analyses we pooled Mexican Americans and non-Hispanic whites to achieve greater statistical power. Table 3 shows anthropometric and metabolic characteristics of subjects by LDL subclass pattern (B, I, and A). Probability values are shown both for the overall analyses of variance and for pairwise contrasts (A versus B, A versus I, and B versus I). The distributions of LDL subclass type were: B (37.3%), I (12.6%), and A (50.2%). Subjects with pattern B had lower HDL-C and higher total cholesterol, triglyceride, fasting and 2-hour glucose, and insulin concentrations than subjects with other phenotypes. As expected, subjects with pattern B had a lower LDL size. There were no significant relations between LDL pattern and age, BMI, WHR, smoking, alcohol, and LDL concentration. Since the results were very similar for the overall analyses of variance and the simpler B versus A comparison, we excluded subjects with LDL subpattern I in subsequent analyses, although they continued to be included in analyses using LDL size.
LDL size was significantly inversely correlated with age, BMI, WHR, male gender, systolic blood pressure, fasting and 2-hour glucose, fasting and 2-hour insulin, total cholesterol, and triglyceride concentrations and was significantly positively correlated with HDL-C (Table 4). The correlations of metabolic and anthropometric variables with LDL pattern are of similar magnitude to those with LDL size, but the signs are reversed (data not shown). Results in the overall population and in the nondiabetic population were, for the most part, identical. For instance, LDL size was inversely correlated with triglyceride concentrations in all subjects (r= -.628) and in nondiabetic subjects (r=-.622). LDL size was in- versely correlated with 2-hour insulin concentrations in all subjects (r=-.221) and in nondiabetic subjects (/•= -.241). Therefore, in the remainder of this report, diabetic subjects will not be excluded. Table 4 also shows Spearman correlations between LDL size and anthropometric and metabolic variables in men and women separately. Results were similar in both sexes. However, LDL size was more strongly correlated with fasting and 2-hour glucose in women than in men. In addition, LDL size was significantly correlated with BMI and WHR in women but not in men. Further analyses showed similar correlations between LDL size or pattern and other variables in premenopausal and postmenopausal women (data not shown). In postmenopausal women not on estrogens, mean LDL size was 256.7±0.8 A, and in premenopausal women not taking oral contraceptives it was 259.1 ±1.1 A (P=.O48).
We also used multivariate analysis to examine whether there might be different effects of metabolic variables on LDL size in Mexican Americans and non-Hispanic whites. To this end we fit both multiple logistic and multiple linear regression models separately in the two ethnic groups. These analyses indicated that the effects of metabolic variables were similar in each group (data not shown), and therefore the ethnic groups were pooled to increase statistical power. Table 5 shows the results of multiple logistic regression analyses with LDL pattern (B versus A) as the dependent variable. Ethnicity was not a significant predictor of LDL subclass pattern B (model 1). Male gender, 2-hour insulin concentration, and fasting glucose significantly predicted pattern B (model 2). After the addition of triglyceride concentrations (model 3), insulin, triglycerides, and male gender significantly predicted type B pattern. HDL-C predicted the presence of type B independent of triglyceride concentrations (model 5). Table 6 shows multiple linear regression analyses with LDL size as a continuous dependent variable. LDL size was significantly smaller in Mexican Americans after adjustment for gender (model 1). Male gender, WHR, and 2-hour insulin significantly predicted smaller LDL size (model 2). After adjustment for insulin concentrations, however, LDL size did not differ by ethnicity. After the addition of triglyceride concentrations, male gender, triglyceride concentrations, and insulin significantly predicted smaller LDL size. Triglyceride concentrations explained the greatest proportion of the variance in LDL size (39.4%). Low HDL-C also predicted LDL size pattern independently of triglyceride concentrations (model 5). The addition of HDL-C added about 7.6% to the percent of variation explained in LDL size. We repeated multiple linear regression analyses (similar to those in Table 6 , model 2) in men and women separately. In men, only 2-hour insulin concentrations significantly predicted smaller LDL size (/? 2 = 15.0%). In women, 2-hour insulin, 2-hour glucose, and WHR significantly predicted smaller LDL size (R 2 =17.2%). After triglycerides and HDL-C were added to the model, triglyceride, HDL-C, and insulin concentrations predicted smaller LDL size in both men and women, and glucose and WHR predicted smaller LDL size in women. The percent of variation explained (R 2 ) was 44.2% in men and 46.3% in women.
Discussion
The present data indicate that the associations between LDL size or pattern and other variables are similar in Mexican Americans and non-Hispanic whites. Furthermore, LDL size was significantly smaller in Mexican Americans than in non-Hispanic whites. The prevalence of pattern B was also higher in Mexican Americans than in non-Hispanic whites, although this difference was not statistically significant, possibly because of lower power due to the exclusion of subjects with pattern I. In addition, analysis based on the dichotomous LDL subclass pattern B versus A was less statistically powerful than analyses based on LDL size, which has a continuous distribution. However, the ethnic difference in LDL size appeared to be due to the higher triglyceride, glucose, and insulin concentrations in Mexican Americans. In addition, these results suggest that differences in LDL size distribution are unlikely to explain the lower cardiovascular mortality in Mexican American men and similar cardiovascular mortality in Mexican American women relative to their non-Hispanic white counterparts. In fact, smaller, dense LDL in Mexican Americans implies higher CHD risk in this ethnic group. We also found similar relations between LDL size or pattern and other variables in men and women, although there were a few interesting exceptions. Selby et al" report that LDL pattern is associated with WHR in women twins. We observed a similar association in women in multivariate models. Although we did not observe a significant interaction between gender and WHR, BMI, or glucose in multivariate models, this failure could reflect low statistical power due to small numbers of subjects. Both obesity and an unfavorable body fat distribution are associated with small, dense LDL in men and women from Costa Rica. 32 We have shown that the most important determinant of LDL size or pattern is the triglyceride concentration, with an overall correlation of -.628. This correlation was similar in Mexican Americans and non-Hispanic whites and was also similar in men and women. Triglyceride concentration explained 39.4% of the variation in LDL size. Our work confirms earlier work in Caucasians 49 and Costa Ricans 12 on the strong inverse relation between LDL size and triglyceride concentrations. Recently, McNamara et al 33 have shown that changes in triglyceride concentrations are also associated with changes in LDL particle size. We also observed that HDL-C concentrations are significantly positively correlated with LDL size, as have previous reports. 6 -91012 - 33 The association of HDL-C and LDL size was statistically independent of the triglyceride concentration. HDL-C explained about 7.6% of the variation in LDL size after accounting for the effect of triglycerides (Table 6 , model 5). Other significant predictors (gender and insulin concentrations) explained a much smaller percentage of the variation in LDL size.
Our results also indicated that men have smaller, denser LDL particles than women, confirming earlier work. 6 -9 - 10 In our population, as in the previous report, 9 men had higher triglyceride concentrations than women, which might explain part of the gender difference. However, the effect of gender on LDL size was statistically independent of HDL-C and triglycerides, suggesting that higher triglyceride and lower HDL concentrations in men do not explain the entire gender difference. Thus, sex hormones may play a role in LDL composition. Since very-low-density lipoproteins (VLDLs) are the precursors of LDL, it is possible that differing concentrations or distributions of VLDL may influence the resulting LDL size. Sex hormones might influence this conversion of VLDL to LDL, perhaps by affecting hepatic lipase, 34 which acts in the processing of VLDL remnants. 35 We observed smaller LDL size in postmenopausal women than in premenopausal women after excluding subjects taking oral contraceptives or postmenopausal estrogen pills. Campos et al 36 also found decreased LDL size in postmenopausal women relative to premenopausal women. No study has prospectively examined the effect of menopause on LDL subfractions.
In the present study, we did not observe an association of smoking and alcohol intake on LDL size. Smoking has been significantly associated with small, dense LDL in women but not in men. 10 In the Framingham Study no association of smoking with LDL size was observed. 7 We also found an inverse correlation of LDll size with systolic blood pressure. Inverse correlations are reported between LDL size and blood pressure" as well as with /3-blocker use. may be associated with small, dense LDL. In the Kaiser Female Twin Study 11 and in obese subjects 8 these associations were independent of triglyceride concentrations. Our results also indicated that small LDL size was associated with increased fasting and 2-hour insulin concentrations in both men and women, independent of triglyceride and HDL concentrations. These associations were also observed in nondiabetic subjects (data not shown). Thus, small, dense LDL may be part of syndrome X, also known as the insulin resistance syndrome. 3839 This syndrome posits that insulin resistance causes a number of other metabolic disorders and end points, including elevated triglyceride concentrations, decreased HDL-C, impaired glucose tolerance, diabetes, hypertension, and CHD.
LDL size was more strongly correlated with glucose concentrations in women than in men. Barakat et al 8 and Campos et al 7 suggest that diabetic subjects have smaller, denser LDL than nondiabetic subjects. Neither of these studies examined whether the association between diabetes and LDL size was independent of the higher triglyceride concentrations present in diabetic subjects. We found a significant association between glucose and LDL size after adjusting for triglyceride and HDL-C concentrations in women. Feingold et al 40 reported that normolipidemic diabetic men had smaller, denser LDL than normolipidemic nondiabetic men. These authors also showed that clearance of triglyceride-rich lipoproteins was decreased in subjects with LDL subclass pattern B relative to subjects with LDL subclass pattern A.
In summary, we have shown that serum triglyceride and HDL concentrations are the most important correlates of LDL size and pattern in both Mexican Americans and non-Hispanic whites. We also found significant independent effects of insulin concentrations and gender on LDL size. Our results suggest that small, dense LDL may be related to the insulin resistance syndrome, which may influence LDL size independent of changes in triglyceride concentrations. Since we have shown that women have larger LDL size than men even after taking into account differences in triglyceride concentrations, we postulate that sex hormones might modify LDL size as well. Lastly, we have observed that LDL size was smaller in Mexican Americans than in non-Hispanic whites. This difference, however, appears to be associated with higher triglyceride, glucose, and insulin concentrations in Mexican Americans. Differences in LDL size are unlikely to explain the relative protection from cardiovascular disease that Mexican Americans enjoy relative to non-Hispanic whites.
